Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRTG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927849 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MCMDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSME3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC728730 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLP1R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SGCB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLIPR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRNB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMARCA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSN1S2AP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HGSNAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDPCP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on